MELISSA NAEGER: Open Payments
NPI 1538616362 · STE GENEVIEVE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 23 payments from 10 companies in 2025. Trend: 2023 $759 · 2024 $422 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $89 |
| PFIZER INC. | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| ABBVIE INC. | 3 | $60 |
| Lilly USA, LLC | 2 | $39 |
| Boston Scientific Corporation | 1 | $35 |
| Viatris Specialty LLC | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Grifols USA, LLC | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: LEQVIO, Ozempic, NURTEC ODT, UBRELVY, MOUNJARO, AMS 700, YUPELRI, FREESTYLE LIBRE.
Industry payments across MO — which companies pay providers there.
